Skip to content
Open access · OA via Europe PMC

The Bidirectional Role of Cellular Senescence in the Treatment of Ovarian Cancer.

Yuan D, Chen M, Wei J, Zhang Y, Li Y, Tang N, Han C, Zhou Y.

Biomedicines · 2026

Abstract

Cellular senescence(definition) plays a complex and crucial dual role in ovarian cancer treatment: it serves as both an important tumor suppression mechanism and a potential driver of drug resistance and recurrence. This review systematically examines the intricate regulatory network of cellular senescence, encompassing multiple pathways including telomere(definition) dysfunction, DNA damage response, epigenetic remodeling, hormone signaling, and metabolic reprogramming. Studies have demonstrated that core therapeutic modalities, such as platinum-based chemotherapy, PARP inhibitors, and CDK4/6 inhibitors, can exert anti-tumor effects by inducing cellular senescence; however, their efficacy is significantly influenced by the senescence-associated secretory phenotype (SASP). Specific SASP components can activate immune surveillance, whereas others promote tumor progression, acquisition of stem cell-like characteristics, and therapeutic resistance. It is this "anti-tumor versus pro-tumor" paradox that renders senescent cells a critical variable determining treatment outcomes. In light of this, emerging strategies aim to precisely modulate the senescence process, including the use of epigenetic drugs to induce senescence, targeting metabolic vulnerabilities to eliminate senescent cells, and intervening in deleterious SASP to improve the tumor microenvironment. Integrating such strategies with conventional therapies holds promise for overcoming the resistance bottleneck in ovarian cancer and opening new avenues for improving patient prognosis.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
Europe PMC
DOI
10.3390/biomedicines14081797
Canonical
link ↗
Fetched
2026-10-08 MST

Cite this

APA
D, Y., M, C., J, W., Y, Z., Y, L., N, T., C, H., &amp; Y., Z. (2026). The Bidirectional Role of Cellular Senescence in the Treatment of Ovarian Cancer. <em>Biomedicines</em>. https://doi.org/10.3390/biomedicines14081797
Vancouver
D Y, M C, J W, Y Z, Y L, N T, et al. The Bidirectional Role of Cellular Senescence in the Treatment of Ovarian Cancer. Biomedicines. 2026. doi:10.3390/biomedicines14081797.
BibTeX
@article{yuan2026TheBid, title = {The Bidirectional Role of Cellular Senescence in the Treatment of Ovarian Cancer.}, author = {Yuan D and Chen M and Wei J and Zhang Y and Li Y and Tang N and Han C and Zhou Y.}, journal = {Biomedicines}, year = {2026}, doi = {10.3390/biomedicines14081797}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings